ArticleBioprocess and biosystems engineering2025
Innovative bacterial consortia for simulated dairy wastewater treatment: improving COD removal efficiency.
Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in microbial biotechnology for sustainable wastewater reclamation: recent trends and future prospects.World journal of microbiology & biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dairy industry generates wastewater characterized by organic components, predominantly composed of proteins and fats, which can be effectively treated through biological processes. The present study aims to develop a bacterial consortium for bio-augmentation to enhance the treatment of simulated dairy wastewater. A total of 75 bacterial isolates were obtained using direct (DI) and enrichment-isolation (EI) methods. Among these, four strains exhibiting the highest proteolytic and lipolytic activities within 24 h were selected for further investigations. The isolates were screened based on their extracellular enzyme activities (proteinase and lipase), as well as their maximum lipolytic (0.3-0.7 mm/h) and proteolytic activity (0.67-0.83 mm/h) by a novel approach of rate of diffusion on TA and MSMA, respectively. The selected strains were identified by 16S rRNA gene sequencing as Massilia (DSSC1), Brevibacillus (ENAT1), Pseudomonas (ENOG5), and Lysinibacillus (ETOG2). The biodegradation potential of individual strains and their consortium was assessed through COD reduction in simulated dairy wastewater. The individual bacterial strains achieved COD reductions from an initial concentration of 3.82 g/L to 2.95, 2.81, 2.48, and 2.89 g/L. In contrast, bio-augmentation with the bacterial consortia reduced COD to 2.19 g/L, resulting in a 26-86% higher reduction compared to the individual strains. This study presents the first report on the use of a novel approach of diffusion-based assay to develop an effective and innovative bacterial consortium for efficient dairy wastewater treatment. These findings highlight the potential of this approach toward enhancing biodegradation efficiency and advancing sustainable wastewater management practice.
Indexed as
Identifiers
40668368What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.